Insights
Search Results
News Articles
8.08.24
IFLR1000 Recognizes Wilson Sonsini Practices, Attorneys in 2024 Guide
In the 2024 edition of its annual guide, IFLR recognized Wilson Sonsini practices and attorneys for their work in the financial and corporate sectors in the U.S. and China. The guide uses in-depth market analysis and interviews with practitioners and clients to determine leading financial and corporate law firms worldwide. Wilson Sonsini’s rankings are summarized below.
Client Highlights
6.18.24
Wilson Sonsini Advises Iambic Therapeutics on $50 Million Series B Extension, Bringing Total Series B Funding to Over $150 Million
On June 18, 2024, Iambic Therapeutics (Iambic), a clinical-stage biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the closing of an oversubscribed $50 million extension, bringing the total Series B funding to over $150 million. The Series B extension was led by new investors Mubadala Capital and Exor Ventures, and existing investors Abingworth, Illumina Ventures, Nexus Venture Partners, Coatue, and Tao Capital Partners. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
Client Highlights
10.03.23
Firm Advises Iambic Therapeutics on $100 Million Series B Financing
On October 3, 2023, Iambic Therapeutics, a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the closing of an oversubscribed $100 million Series B financing. The financing was co-led by Ascenta Capital and Abingworth, and included new investors NVIDIA and Illumina Ventures. Existing investors also participated, including Nexus Ventures, Catalio Capital Management, Coatue, FreeFlow, OrbiMed, and Sequoia Capital. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
News Articles
8.01.23
Wilson Sonsini Practices and Attorneys Recognized in 2023 IFLR1000 Guide
In the recent 2023 edition of its annual guide, the IFLR1000 recognized numerous Wilson Sonsini practices and attorneys for their work in the financial and corporate sectors. The guide uses in-depth market analysis and interviews with practitioners and clients to determine leading financial and corporate law firms worldwide. Wilson Sonsini’s rankings are summarized below.
Client Highlights
8.12.21
Wilson Sonsini Advises Dija on Acquisition by Gopuff
On August 11, 2021, Gopuff, the go-to solution for immediate everyday needs, announced that it has signed a definitive agreement to acquire Dija, a leading European delivery platform providing consumers daily essentials in minutes. Wilson Sonsini Goodrich & Rosati advised Dija on the transaction in collaboration with Taylor Wessing, which served as UK counsel on the transaction.
Following Gopuff’s recent acquisition of UK-based Fancy—a transaction in which Wilson Sonsini advised Fancy—this latest deal is expected to accelerate Gopuff’s international expansion by establishing an immediate presence in France and Spain and providing further densification in the UK. Through the acquisitions of Dija and Fancy, Gopuff plans to operate in three European countries with about 40 micro-fulfillment centers and 200 employees in the region, with additional plans for continued, rapid expansion. In June 2021, Gopuff also announced its acquisition of San Francisco-based rideOS, a start-up that builds cutting-edge proprietary technology for advanced routing, on-demand dispatch, and fleet optimization for the fast-growing delivery and logistics industries; Wilson Sonsini advised rideOS in that transaction.
Founded in 2020 by delivery industry leaders Alberto Menolascina and Yusuf Saban, Dija has continued to attract top talent across delivery, technology, logistics, and operations. Dija’s experienced team of leaders has powered rapid expansion across the region: today, Dija operates dozens of micro-fulfillment centers across major metropolitan areas including London, Paris, Madrid, Valencia, and more. Following the close of Gopuff’s acquisition of Dija, which is expected within 30 days, Dija will continue to operate under the Dija name in the near term, as the two companies create an integration plan to enhance the customer experience across Europe and the UK.
Following Gopuff’s recent acquisition of UK-based Fancy—a transaction in which Wilson Sonsini advised Fancy—this latest deal is expected to accelerate Gopuff’s international expansion by establishing an immediate presence in France and Spain and providing further densification in the UK. Through the acquisitions of Dija and Fancy, Gopuff plans to operate in three European countries with about 40 micro-fulfillment centers and 200 employees in the region, with additional plans for continued, rapid expansion. In June 2021, Gopuff also announced its acquisition of San Francisco-based rideOS, a start-up that builds cutting-edge proprietary technology for advanced routing, on-demand dispatch, and fleet optimization for the fast-growing delivery and logistics industries; Wilson Sonsini advised rideOS in that transaction.
Founded in 2020 by delivery industry leaders Alberto Menolascina and Yusuf Saban, Dija has continued to attract top talent across delivery, technology, logistics, and operations. Dija’s experienced team of leaders has powered rapid expansion across the region: today, Dija operates dozens of micro-fulfillment centers across major metropolitan areas including London, Paris, Madrid, Valencia, and more. Following the close of Gopuff’s acquisition of Dija, which is expected within 30 days, Dija will continue to operate under the Dija name in the near term, as the two companies create an integration plan to enhance the customer experience across Europe and the UK.
Client Highlights
6.28.21
Wilson Sonsini Advises Codex DNA on $122 Million IPO
On June 22, 2021, Codex DNA announced the closing of its initial public offering of 7,666,664 shares of common stock, including the full exercise of the underwriters’ option to purchase up to 999,999 additional shares of common stock, at a public offering price of $16.00 per share. The aggregate gross proceeds to Codex DNA from the offering were approximately $122.7 million, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Codex DNA. The company's common stock began trading on The Nasdaq Global Select Market on June 18, 2021, under the ticker symbol "DNAY."
Client Highlights
6.11.21
Wilson Sonsini Represents Nautilus Biotechnology in $345 Million Business Combination with Arya Sciences Acquisition Corp III; NAUT Begins Trading on Nasdaq Global Select Market
On June 9, 2021, Nautilus Biotechnology, a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the completion of its business combination with Arya Sciences Acquisition Corp III, a special purpose acquisition company (SPAC) sponsored by Perceptive Advisors. The combined company, Nautilus Biotechnology, began trading shares of its common stock under the ticker symbol "NAUT" on the Nasdaq Global Select Market on June 10, 2021. The business combination was approved by Arya III’s shareholders on June 8, 2021. Gross proceeds from this transaction totaled approximately $345 million, which included approximately $145 million of funds held in Arya III’s trust account and the concurrent common stock private investment in public equity (PIPE) financing of $200 million led by Perceptive Advisors, an affiliate of Arya III’s sponsor, as well as RA Capital Management, Ally Bridge Group, Bain Capital Life Sciences, Franklin Templeton Investments, OrbiMed, Alyeska Investment Group, L.P., Casdin Capital, and existing Nautilus Biotechnology shareholders including Andreessen Horowitz, Madrona Venture Group, and Vulcan Capital.
Client Highlights
2.09.21
Firm Advises Nautilus Biotechnology on Merger with Arya Sciences Acquisition Corp III
On February 8, 2021, Nautilus Biotechnology, Inc., a biotechnology company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III, a special purpose acquisition company, or SPAC, sponsored by Perceptive Advisors, announced that they have entered into a definitive business combination agreement. Wilson Sonsini Goodrich & Rosati is advising Nautilus Biotechnology on the transaction.
Client Highlights
12.01.20
Wilson Sonsini Advises Collectors Universe in Acquisition by Investor Group
On November 30, 2020, Collectors Universe, a leader in third-party grading and authentication services for high-value collectibles, announced that it had entered into a definitive agreement under which an investor group led by entrepreneur and sports card collector Nat Turner, D1 Capital Partners, L.P., and Cohen Private Ventures, LLC, will acquire all of Collectors Universe’s outstanding shares of common stock for $75.25 per share in cash. Wilson Sonsini Goodrich & Rosati advised Collectors Universe on the transaction.
Client Highlights
5.22.20
Wilson Sonsini Represents Nautilus in $76 Million Series B Funding
On May 21, 2020, Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, announced it has raised $76 million in an oversubscribed Series B offering that closed on May 18, placing the company's total funding in excess of $100 million. Wilson Sonsini Goodrich & Rosati represented Nautilus in the transaction.
Client Highlights
4.10.20
Wilson Sonsini Advises MaxLinear in Acquisition of Intel Division
On April 6, 2020, MaxLinear, Inc., a leading provider of radio frequency and mixed-signal integrated circuits for broadband communications, announced that it had entered into a definitive agreement with Intel Corporation to acquire Intel’s Home Gateway Platform Division assets in an all-cash, asset transaction valued at $150 million. Wilson Sonsini Goodrich & Rosati is advising MaxLinear in the transaction.
Client Highlights
3.29.17
MaxLinear to Acquire Exar Corporation
On March 29, 2017, MaxLinear, a leading semiconductor company, and Exar Corporation, a designer and developer of high-performance analog mixed-signal ICs and sub-system solutions, announced that they have entered into a definitive agreement under which MaxLinear has agreed to acquire Exar for approximately $700 million. Wilson Sonsini Goodrich & Rosati represented MaxLinear in the transaction.